Researchers have cleared the last scientific hurdle to a clinical trial of gene therapy to cure sickle cell disease, they reported on Tuesday, fueling hopes that they will begin enrolling patients early next year. But they dodged a bullet

Quick Read

The most expensive drugs in history, or medicine’s biggest bargains? Gene therapy could be both

Quick Read

A treatment now pending approval in Europe will be the first commercial gene therapy to provide an outright cure for a deadly disease. The treatment is a landmark for gene-replacement technology, an idea that’s struggled for three decades to prove itself safe and practical

Quick Read

Researchers explored the ethical concerns of the treatment in a clinical trial, finding most women and medical organizations view such research positively

Quick Read

Positive news buoys a beleaguered field, but treatment benefits may fade

Quick Read

An American biotech CEO claims she is the first to undergo gene therapy to reverse aging. Judge for yourself

Quick Read

Both art and science remind us of the significant ethical challenges presented by new advances in genetics

Read More